All of the latest news from the forklift industry only on the

Good luck to the Briggs Cycle Team

Today five Brigg’s cyclists take on their latest challenge – to ride the 350 miles from Briggs’ offices in Cumbernauld to Cannock in just five days.

Peter Jones, Andrew Keyworth, Adam Alderson and Kathryn Hyde will start their journey today and have a tough five days ahead of them.

The team originally set themselves a goal of raising £5,000 for their new charity of the year, however have already raised over £7,000 for Alzheimer’s Research UK. There are currently no treatments to slow, stop or prevent the diseases that cause dementia and one in three people born today will die from the condition, unless we discover a cure. Every penny raised will help fund life-changing dementia research and make a difference for generations to come. The route follows part of the tried and tested Lands’ End to John O’ Groats route for a large part of the ride.

13/09/18: Cumbernauld – Abington (47.2 miles)

14/09/18: Abingdon – Penrith (93.6 miles)

15/09/18: Penrith – Whalley (80 miles)

16/09/18: Whalley – Chesterfield (75.2 miles)

17/09/18: Chesterfield – Cannock (54 miles)

Total mileage: 350 miles

The team have already raised over £6,500 for the cause, thanks to our fantastic suppliers who have donated significant amounts of money to help us support the charity. Special thanks go to Hako, Hoppecke, Combilift, Pall-ex, Fork Truck Control, Secondsight, Baumann Attachments, HSBC, CIRM, Travis Perkins, Pinsent Masons, Dbfb Communications, Inchcape, Interfit Ltd, Cascade Attachments and Hyster Yale Group.

The Briggs Cycle Team


Katy Abraham, Corporate Partnerships Officer at Alzheimer’s Research UK, said:

“Good luck to the whole team who are taking on this gruelling cycle challenge in aid of dementia research. They’ve already raised an incredible amount of money for Alzheimer’s Research UK and this will make a huge difference to everyone impacted by dementia. Thanks to their support, we will be able to invest in the pioneering research that will lead us to a cure. We can’t wait to hear how they get on!”



stay informed!

Subscribe to receive exclusive content and notifications